UniSuper Management Pty Ltd boosted its holdings in shares of Humana Inc. (NYSE:HUM - Free Report) by 32.8% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 11,227 shares of the insurance provider's stock after buying an additional 2,770 shares during the quarter. UniSuper Management Pty Ltd's holdings in Humana were worth $2,848,000 as of its most recent SEC filing.
A number of other large investors also recently bought and sold shares of the business. Transcend Capital Advisors LLC lifted its position in shares of Humana by 399.7% during the fourth quarter. Transcend Capital Advisors LLC now owns 3,643 shares of the insurance provider's stock valued at $924,000 after buying an additional 2,914 shares during the last quarter. FNY Investment Advisers LLC lifted its position in Humana by 6,647.5% during the fourth quarter. FNY Investment Advisers LLC now owns 27,260 shares of the insurance provider's stock valued at $6,916,000 after acquiring an additional 26,856 shares during the last quarter. Retirement Systems of Alabama boosted its stake in Humana by 735.9% in the fourth quarter. Retirement Systems of Alabama now owns 219,002 shares of the insurance provider's stock valued at $55,563,000 after acquiring an additional 192,801 shares in the last quarter. Charles Schwab Investment Management Inc. grew its holdings in Humana by 7.3% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 964,926 shares of the insurance provider's stock worth $244,811,000 after purchasing an additional 65,735 shares during the last quarter. Finally, PDT Partners LLC grew its holdings in Humana by 190.0% in the third quarter. PDT Partners LLC now owns 4,060 shares of the insurance provider's stock worth $1,286,000 after purchasing an additional 2,660 shares during the last quarter. Institutional investors own 92.38% of the company's stock.
Analyst Ratings Changes
A number of analysts have recently weighed in on HUM shares. Barclays raised their price objective on Humana from $255.00 to $270.00 and gave the stock an "equal weight" rating in a research report on Thursday, February 13th. StockNews.com downgraded Humana from a "buy" rating to a "hold" rating in a report on Tuesday, March 18th. Truist Financial upped their price objective on shares of Humana from $260.00 to $290.00 and gave the company a "hold" rating in a report on Monday, January 6th. Cantor Fitzgerald reiterated a "neutral" rating and issued a $290.00 target price on shares of Humana in a research note on Wednesday, February 12th. Finally, JPMorgan Chase & Co. cut their price target on shares of Humana from $257.00 to $256.00 and set a "neutral" rating on the stock in a research note on Tuesday, February 18th. Eighteen research analysts have rated the stock with a hold rating and five have given a buy rating to the company's stock. According to MarketBeat.com, Humana presently has an average rating of "Hold" and an average price target of $285.68.
Get Our Latest Report on Humana
Humana Stock Performance
HUM traded down $0.05 on Tuesday, reaching $264.55. The stock had a trading volume of 927,232 shares, compared to its average volume of 1,753,344. The business's 50-day moving average price is $269.77 and its two-hundred day moving average price is $273.07. The company has a market cap of $31.93 billion, a P/E ratio of 26.59, a price-to-earnings-growth ratio of 2.05 and a beta of 0.57. Humana Inc. has a 12-month low of $213.31 and a 12-month high of $406.46. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.68.
Humana (NYSE:HUM - Get Free Report) last posted its earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) EPS for the quarter, beating analysts' consensus estimates of ($2.26) by $0.10. Humana had a return on equity of 11.70% and a net margin of 1.02%. Sell-side analysts forecast that Humana Inc. will post 16.47 earnings per share for the current year.
Humana Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be given a dividend of $0.885 per share. The ex-dividend date of this dividend is Friday, March 28th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.34%. Humana's dividend payout ratio (DPR) is 35.58%.
Humana Company Profile
(
Free Report)
Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.
Featured Stories

Before you consider Humana, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Humana wasn't on the list.
While Humana currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.